Search research articles
Contact Us
Filters
Showing results (211-220 of 692) with videos related to
Page
of 70
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2020
RepeatModeler2 for automated genomic discovery of transposable element families
Jullien M Flynn, Robert Hubley, Clément Goubert, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 12, 2004
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA
J T Annema, O S Hoekstra, E F Smit, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2017
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
C Dickhoff, M Dahele, E F Smit, et al.
The American Journal of Medicine
|
August 1, 1990
Decreased phenytoin level after carboplatin treatment
A S Dofferhoff, H H Berendsen, J vd Naalt, et al.
Pharmacoeconomics
|
December 29, 2011
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review
Mathilda L Bongers, Veerle M H Coupé, Elise P Jansma, et al.
Journal of Ethnopharmacology
|
July 7, 1995
Ayurvedic herbal drugs with possible cytostatic activity
H F Smit, H J Woerdenbag, R H Singh, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
March 17, 2006
[The prevention of psychiatric disorders]
A T F Beekman, P Cuijpers, H W J van Marwijk, et al.
Clinical Lung Cancer
|
September 23, 2014
Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechallenge in advanced NSCLC patients with an activating EGFR mutation who responded to an EGFR-TKI used as first-line or previous treatment
Justine L Kuiper, Danielle A M Heideman, Tom Würdinger, et al.
Experimental Cell Research
|
June 23, 2015
Effects of helium on inflammatory and oxidative stress-induced endothelial cell damage
Kirsten F Smit, Raphaela P Kerindongo, Anita Böing, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2003
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)
R Dziadziuszko, A Ardizzoni, P E Postmus, et al.
Page
of 70
Search research articles
Search
Showing results (211-220 of 692) with videos related to
Sort By:
Page
of 70
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2020
RepeatModeler2 for automated genomic discovery of transposable element families
Jullien M Flynn, Robert Hubley, Clément Goubert, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 12, 2004
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA
J T Annema, O S Hoekstra, E F Smit, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2017
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
C Dickhoff, M Dahele, E F Smit, et al.
The American Journal of Medicine
|
August 1, 1990
Decreased phenytoin level after carboplatin treatment
A S Dofferhoff, H H Berendsen, J vd Naalt, et al.
Pharmacoeconomics
|
December 29, 2011
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review
Mathilda L Bongers, Veerle M H Coupé, Elise P Jansma, et al.
Journal of Ethnopharmacology
|
July 7, 1995
Ayurvedic herbal drugs with possible cytostatic activity
H F Smit, H J Woerdenbag, R H Singh, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
March 17, 2006
[The prevention of psychiatric disorders]
A T F Beekman, P Cuijpers, H W J van Marwijk, et al.
Clinical Lung Cancer
|
September 23, 2014
Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechallenge in advanced NSCLC patients with an activating EGFR mutation who responded to an EGFR-TKI used as first-line or previous treatment
Justine L Kuiper, Danielle A M Heideman, Tom Würdinger, et al.
Experimental Cell Research
|
June 23, 2015
Effects of helium on inflammatory and oxidative stress-induced endothelial cell damage
Kirsten F Smit, Raphaela P Kerindongo, Anita Böing, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2003
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)
R Dziadziuszko, A Ardizzoni, P E Postmus, et al.
Page
of 70